{"title": "Vaccine could help address the opioid epidemic", "title_detail": {"type": "text/plain", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/vaccines.xml", "value": "Vaccine could help address the opioid epidemic"}, "links": [{"rel": "alternate", "type": "text/html", "href": "https://www.sciencedaily.com/releases/2018/12/181213083650.htm"}], "link": "https://www.sciencedaily.com/releases/2018/12/181213083650.htm", "summary": "Synthetic psychoactive drugs have become a serious public health threat in recent years. This is particularly true of the fentanyls, a large family of synthetic opioids, which can be up to 10,000 times more potent than morphine. Synthetic opioids are highly addictive and, because of their potency, often prove fatal: among the roughly 72,000 drug overdose deaths in the US in 2017, some 30,000 were related to synthetic opioids.", "summary_detail": {"type": "text/html", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/vaccines.xml", "value": "Synthetic psychoactive drugs have become a serious public health threat in recent years. This is particularly true of the fentanyls, a large family of synthetic opioids, which can be up to 10,000 times more potent than morphine. Synthetic opioids are highly addictive and, because of their potency, often prove fatal: among the roughly 72,000 drug overdose deaths in the US in 2017, some 30,000 were related to synthetic opioids."}, "published": "Thu, 13 Dec 2018 08:36:50 EST", "published_parsed": [2018, 12, 13, 13, 36, 50, 3, 347, 0], "id": "https://www.sciencedaily.com/releases/2018/12/181213083650.htm", "guidislink": false}